ENTASIS THERAPEUTICS HOLDINGS INC. Increase (Decrease) in Prepaid Expense and Other Assets
ENTASIS THERAPEUTICS HOLDINGS INC. reported Increase (Decrease) in Prepaid Expense and Other Assets of $3.73 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2019-11-14
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-09-30 was $328.00K, a 33.20% decline year-over-year.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-06-30 was $855.00K, a 21.34% decline year-over-year.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-03-31 was $2.55M, a 701.26% increase year-over-year.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2018-12-31 was -$399.00K.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $1.50M, a 333.91% increase from fiscal 2017.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $345.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2019-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.18M derived: sum of 2 quarters · filed 2019-11-14 | $3.73M 10-Q · filed 2019-11-14 | $3.33M derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | $855.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $3.40M 10-Q · filed 2019-08-12 | $3.00M derived: sum of 3 quarters · filed 2019-08-12 | $3.50M derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-03-31 | $2.55M 10-Q · filed 2019-05-14 | $2.15M derived: sum of 2 quarters · filed 2019-05-14 | $2.64M derived: sum of 3 quarters · filed 2019-11-14 | $3.73M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-12-31 | -$399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $92.00K derived: sum of 2 quarters · filed 2019-11-14 | $1.18M derived: sum of 3 quarters · filed 2019-11-14 | $1.50M 10-K · filed 2019-03-29 |
| 2018-09-30 | $491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.58M derived: sum of 2 quarters · filed 2019-11-14 | $1.90M 10-Q · filed 2019-11-14 | $1.37M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.41M 10-Q · filed 2019-08-12 | $875.00K derived: sum of 3 quarters · filed 2019-08-12 | |
| 2018-03-31 | $318.00K 10-Q · filed 2019-05-14 | -$212.00K derived: sum of 2 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $345.00K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $875.00K 10-Q · filed 2018-11-14 |